• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类卵巢癌微环境中的动态炎症细胞因子网络。

A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.

机构信息

Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, Cancer Research UK, Bioinformatics and Biostatistics Service, London, United Kingdom.

出版信息

Cancer Res. 2012 Jan 1;72(1):66-75. doi: 10.1158/0008-5472.CAN-11-2178. Epub 2011 Nov 7.

DOI:10.1158/0008-5472.CAN-11-2178
PMID:22065722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3252703/
Abstract

Constitutive production of inflammatory cytokines is a characteristic of many human malignant cell lines; however, the in vitro and in vivo interdependence of these cytokines, and their significance to the human cancer microenvironment, are both poorly understood. Here, we describe for the first time how three key cytokine/chemokine mediators of cancer-related inflammation, TNF, CXCL12, and interleukin 6, are involved in an autocrine cytokine network, the "TNF network," in human ovarian cancer. We show that this network has paracrine actions on angiogenesis, infiltration of myeloid cells, and NOTCH signaling in both murine xenografts and human ovarian tumor biopsies. Neutralizing antibodies or siRNA to individual members of this TNF network reduced angiogenesis, myeloid cell infiltration, and experimental peritoneal ovarian tumor growth. The dependency of network genes on TNF was shown by their downregulation in tumor cells from patients with advanced ovarian cancer following the infusion of anti-TNF antibodies. Together, the findings define a network of inflammatory cytokine interactions that are crucial to tumor growth and validate this network as a key therapeutic target in ovarian cancer.

摘要

炎症细胞因子的组成性产生是许多人类恶性细胞系的特征;然而,这些细胞因子在体外和体内的相互依赖性及其对人类癌症微环境的意义都知之甚少。在这里,我们首次描述了三种关键的癌症相关炎症细胞因子/趋化因子介质 TNF、CXCL12 和白细胞介素 6 如何参与人类卵巢癌中的自分泌细胞因子网络“TNF 网络”。我们表明,该网络在小鼠异种移植物和人类卵巢肿瘤活检中具有旁分泌作用,可影响血管生成、髓样细胞浸润和 NOTCH 信号传导。针对该 TNF 网络中单个成员的中和抗体或 siRNA 可减少血管生成、髓样细胞浸润和实验性腹膜卵巢肿瘤生长。通过输注抗 TNF 抗体后,晚期卵巢癌患者肿瘤细胞中网络基因的下调,显示出它们对 TNF 的依赖性。总之,这些发现定义了一个炎症细胞因子相互作用网络,这对肿瘤生长至关重要,并将该网络验证为卵巢癌的一个关键治疗靶点。

相似文献

1
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.人类卵巢癌微环境中的动态炎症细胞因子网络。
Cancer Res. 2012 Jan 1;72(1):66-75. doi: 10.1158/0008-5472.CAN-11-2178. Epub 2011 Nov 7.
2
The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.炎性细胞因子肿瘤坏死因子-α在上皮性卵巢癌细胞中产生自分泌肿瘤促进网络。
Cancer Res. 2007 Jan 15;67(2):585-92. doi: 10.1158/0008-5472.CAN-06-2941.
3
Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells.整合转录组学和蛋白质组学分析确定蛋白激酶CK2是卵巢癌细胞炎症细胞因子网络中的关键信号节点。
Oncotarget. 2016 Mar 29;7(13):15648-61. doi: 10.18632/oncotarget.7255.
4
Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype.HOXA9 基因在卵巢癌中的表达诱导腹腔巨噬细胞获得促进肿瘤的 M2 表型。
Am J Pathol. 2014 Jan;184(1):271-81. doi: 10.1016/j.ajpath.2013.09.017.
5
Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium.肿瘤坏死因子α在正常和恶性卵巢上皮中的表达与调控
Mol Cancer Ther. 2006 Feb;5(2):382-90. doi: 10.1158/1535-7163.MCT-05-0303.
6
Interleukin-6 as a therapeutic target in human ovarian cancer.白细胞介素 6 作为人类卵巢癌的治疗靶点。
Clin Cancer Res. 2011 Sep 15;17(18):6083-96. doi: 10.1158/1078-0432.CCR-11-0945. Epub 2011 Jul 27.
7
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.CXCR2 通过调控细胞周期、减少细胞凋亡和促进血管生成促进卵巢癌细胞生长。
Clin Cancer Res. 2010 Aug 1;16(15):3875-86. doi: 10.1158/1078-0432.CCR-10-0483. Epub 2010 May 26.
8
Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.血管内皮生长因子 c 通过旁分泌和自分泌机制促进卵巢癌的进展。
Am J Pathol. 2014 Apr;184(4):1050-1061. doi: 10.1016/j.ajpath.2013.12.030. Epub 2014 Feb 6.
9
Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.溶血磷脂酸诱导肿瘤坏死因子-α调节卵巢癌细胞中的促炎细胞因子网络。
FASEB J. 2020 Oct;34(10):13935-13948. doi: 10.1096/fj.202001136R. Epub 2020 Aug 26.
10
CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.CYR61 是上皮性卵巢癌肿瘤微环境中肿瘤进展的炎症反应的一个潜在生物标志物。
BMC Cancer. 2019 Nov 25;19(1):1140. doi: 10.1186/s12885-019-6321-x.

引用本文的文献

1
Jamamina: A Green Nanostructured Lipid Carrier with NaDES and Curcumin for Redox Modulation and Inflammatory Disorders.Jamamina:一种含有天然深共熔溶剂和姜黄素的绿色纳米结构脂质载体,用于氧化还原调节和炎症性疾病
Int J Mol Sci. 2025 Aug 28;26(17):8373. doi: 10.3390/ijms26178373.
2
Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes.通过同时抑制关键代谢酶对癌细胞进行协同靶向治疗。
Cell Death Differ. 2025 Jun 23. doi: 10.1038/s41418-025-01532-5.
3
BNC1 inhibits the development and progression of gastric cancer by regulating the CCL20/JAK-STAT axis.

本文引用的文献

1
Rethinking ovarian cancer: recommendations for improving outcomes.重新思考卵巢癌:改善预后的建议。
Nat Rev Cancer. 2011 Sep 23;11(10):719-25. doi: 10.1038/nrc3144.
2
Interleukin-6 as a therapeutic target in human ovarian cancer.白细胞介素 6 作为人类卵巢癌的治疗靶点。
Clin Cancer Res. 2011 Sep 15;17(18):6083-96. doi: 10.1158/1078-0432.CCR-11-0945. Epub 2011 Jul 27.
3
Integrated genomic analyses of ovarian carcinoma.卵巢癌的综合基因组分析。
BNC1通过调节CCL20/JAK-STAT轴抑制胃癌的发生和发展。
PeerJ. 2025 May 26;13:e19477. doi: 10.7717/peerj.19477. eCollection 2025.
4
A Method for Comparing Proteins Measured in Serum and Plasma by Olink Proximity Extension Assay.一种通过Olink邻位延伸分析比较血清和血浆中蛋白质测量值的方法。
Mol Cell Proteomics. 2025 May 27;24(7):101000. doi: 10.1016/j.mcpro.2025.101000.
5
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements.肿瘤微环境在卵巢癌转移及临床进展中的作用
J Transl Med. 2025 May 14;23(1):539. doi: 10.1186/s12967-025-06508-0.
6
Development and validation of a nomogram to predict recurrence in epithelial ovarian cancer using complete blood count and lipid profiles.利用全血细胞计数和血脂谱建立预测上皮性卵巢癌复发的列线图并进行验证。
Front Oncol. 2025 Feb 3;15:1525867. doi: 10.3389/fonc.2025.1525867. eCollection 2025.
7
Current status and new directions for hepatocellular carcinoma diagnosis.肝细胞癌诊断的现状与新方向
Liver Res. 2024 Dec 5;8(4):218-236. doi: 10.1016/j.livres.2024.12.001. eCollection 2024 Dec.
8
Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer.异质性疾病中的患者代表性细胞系模型:卵巢癌细胞系与卵巢癌之间信号转导通路活性的比较
Cancers (Basel). 2024 Dec 2;16(23):4041. doi: 10.3390/cancers16234041.
9
Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer.糖酵解相关基因预测胃癌的预后并提示免疫微环境特征。
BMC Cancer. 2024 Aug 8;24(1):979. doi: 10.1186/s12885-024-12747-z.
10
Proteomic landscape of epithelial ovarian cancer.上皮性卵巢癌的蛋白质组学概况。
Nat Commun. 2024 Jul 31;15(1):6462. doi: 10.1038/s41467-024-50786-z.
Nature. 2011 Jun 29;474(7353):609-15. doi: 10.1038/nature10166.
4
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.IL6-STAT3-HIF 信号通路与血管生成抑制剂舒尼替尼治疗卵巢透明细胞癌的反应
Clin Cancer Res. 2011 Apr 15;17(8):2538-48. doi: 10.1158/1078-0432.CCR-10-3314. Epub 2011 Feb 22.
5
The genesis and evolution of high-grade serous ovarian cancer.高级别浆液性卵巢癌的发生和演进。
Nat Rev Cancer. 2010 Nov;10(11):803-8. doi: 10.1038/nrc2946. Epub 2010 Oct 14.
6
ARID1A mutations in endometriosis-associated ovarian carcinomas.ARID1A 突变与子宫内膜异位症相关的卵巢癌。
N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.
7
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer.肿瘤特异性 HMG-CoAR 是上皮性卵巢癌无复发生存的独立预测因子。
BMC Cancer. 2010 Apr 1;10:125. doi: 10.1186/1471-2407-10-125.
8
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.肿瘤坏死因子-α(TNF-α)通过 TNFR1 和 IL-17 促进卵巢癌细胞在小鼠和人体内的生长。
J Clin Invest. 2009 Oct;119(10):3011-23. doi: 10.1172/JCI39065. Epub 2009 Sep 8.
9
Cancer-related inflammation.癌症相关炎症
Nature. 2008 Jul 24;454(7203):436-44. doi: 10.1038/nature07205.
10
Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.Jagged-1与Notch3旁分泌环调节卵巢肿瘤的生长和黏附。
Cancer Res. 2008 Jul 15;68(14):5716-23. doi: 10.1158/0008-5472.CAN-08-0001.